4/2/2023 0 Comments Iqos marlboro![]() We believe that PM USA met each of these milestones, but PMI disagreed with our position. Upon achieving additional milestones, PM USA had the option to renew for an additional five-year term through April 2029. commercialization rights upon achieving an initial milestone by April 2022. As part of the 2013 agreement, PM USA had the right to maintain exclusive U.S. Food and Drug Administration (FDA) in April 2019 and continued through April 2024. PM USA’s commercialization rights were subject to an initial five-year term, which began when the system received authorization from the U.S. commercialization rights of PM USA, an Altria subsidiary, to the IQOS system. In 2013, we entered into a series of agreements with PMI related to innovative tobacco products, which included exclusive U.S. “We believe that this agreement provides us with fair compensation and greater flexibility to allocate resources toward Moving Beyond Smoking.” “We remain committed to creating long-term value through our Vision,” said Billy Gifford, Altria’s Chief Executive Officer. commercialization rights to the IQOS Tobacco Heating System® effective April 30, 2024. (PMI) under which Altria will receive cash payments from PMI totaling approximately $2.7 billion (pre-tax) in exchange for assigning exclusive U.S. (NYSE:MO) today announced that a subsidiary has entered into an agreement (the Agreement) with a subsidiary of Philip Morris International Inc. commercialization rights to the IQOS system effective April 30, 2024.Īltria gains greater flexibility to allocate resources toward Moving Beyond Smoking.Īltria Group, Inc. Altria to receive cash payments from Philip Morris International of approximately $2.7 billion in exchange for assigning exclusive U.S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |